Impact pronostique du délai d'induction de la radiothérapie adjuvante dans le cancer du sein

Lesage, Margaux; Pilloy, Joseph; Fleurier, C.; Cirier, Julien; Jourdan, Michel; Arbion, Flavie; Body, G.; Ouldamer, Lobna

doi:10.1016/j.gofs.2019.03.001

Cited by 4 publications

(1 citation statement)

References 69 publications

(56 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Aangenomen wordt dat uitstel van adjuvante radiotherapie de overleving van de patiënt op lange termijn negatief zou kunnen beïnvloeden. 5 In deze retrospectieve studie werden 150 patiënten geïncludeerd, van wie de meeste oncoplastische BSC kregen via het reductiepatroon. Complicaties traden op bij 37,5% van de patiënten binnen 1 jaar na oncoplastische BSC.…”

unclassified

Challenges in breast reconstruction after breast cancer

Hillberg

View full text Add to dashboard Cite

published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User

show abstract

unclassified

Challenges in breast reconstruction after breast cancer

Hillberg

View full text Add to dashboard Cite

show abstract

Factors delaying non‐metastatic breast cancer adjuvant therapy and impact on prognosis in a cohort of Brazilian women

Veiga,

Medeiros,

de Aguiar

et al. 2024

Evaluation Clinical Practice

View full text Add to dashboard Cite

ObjectiveTo identify factors associated with delays in beginning adjuvant therapy and prognosis impacts on non‐metastatic breast cancer patients.MethodsThis assessment comprised a prospective cohort study concerning breast cancer patients treated at a public oncology centre. A time interval of ≥60 days between surgery and the beginning of the first adjuvant treatment was categorised as a delay. Factors associated with delays were evaluated through logistic regression analysis and the prognosis effects were assessed by a Cox regression analysis.ResultsThe median time interval between surgery and the first adjuvant treatment for the 401 women included in this study was of 57.0 days (37.0–93.0). Independent factors associated with delays comprised not presenting an overexpression of the HER‐2 protein, not having undergone neoadjuvant chemotherapy, and having undergone chemotherapy or other therapeutic modalities other than hormone therapy and chemotherapy as the first adjuvant treatment. Delays did not affect recurrence, distant metastasis, or death risks. Factors associated with recurrence and distant metastasis risks comprised a clinical staging ≥2B, having undergone neoadjuvant chemotherapy, presenting the luminal molecular subtype B and triple‐negative tumours, and having children. Factors associated with death comprised triple‐negative molecular tumours and neoadjuvant chemotherapy.ConclusionDelays in beginning adjuvant treatment did not affect the prognosis of non‐metastatic breast cancer patients. Clinical and treatment‐related factors, on the other hand, were associated with delays, and recurrence, distant metastasis, and death risks.

show abstract

Surgery on breast cancer in pregnancy

Liberale¹,

Tripodi²,

Ottino³

et al. 2019

Transl. Cancer Res.

View full text Add to dashboard Cite

Pregnancy-associated breast cancer (PABC) is defined as breast cancer develops either during or within 1 year after pregnancy, it is a rare disease arising in 1:3,000 to 1:10,000 pregnant women. Prognosis of this tumor is influenced by local or systemic treatment, which might be conditioned by gestational age and limited by the concern on potential adverse impact on fetus. The aim of this literature review is to analyze the main topics regarding surgical treatment of patients diagnosed with breast cancer in pregnancy: anesthesia and maternal-fetal monitoring, type of breast surgery, immediate breast reconstruction after radical surgery and management of the axilla. Some important topics remain controversial since the relative rarity of PABC precludes the feasibility of large studies leading to a lack of literature data. Multi-institutional collaboration is warranted to collect women with PABC, in order to best define surgical treatment in view of associated maternal and fetal risks.

show abstract

Impact pronostique du délai d'induction de la radiothérapie adjuvante dans le cancer du sein

Cited by 4 publications

References 69 publications

Challenges in breast reconstruction after breast cancer

Challenges in breast reconstruction after breast cancer

Factors delaying non‐metastatic breast cancer adjuvant therapy and impact on prognosis in a cohort of Brazilian women

Surgery on breast cancer in pregnancy

Contact Info

Product

Resources

About